We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Weakness in ATS is partly offset by strong momentum in the healthtech vertical.
Celestica, Inc. (CLS - Free Report) is scheduled to report fourth-quarter 2025 earnings on Jan. 28. In the to-be-reported quarter, the company is likely to have recorded lower revenues from the Advanced Technology Solutions segment owing to soft demand in some end markets and macroeconomic headwinds.
Factors at Play
The Advanced Technology Solutions (ATS) segment primarily focuses on aerospace and defense (A&D), Industrial, HealthTech and Capital Equipment businesses, which include semiconductor and display verticals.
The company is experiencing weakness in the ATS segment. Elevated inventory levels in the Industrial end markets are primarily hindering net sales growth in this segment. Although demand has stabilized, macroeconomic challenges remain headwinds. Demand in the semiconductor capital equipment market remains soft. Foundries also constrained spending on capacity buildup due to a clouded outlook in the future demand stemming from tariff and trade-related uncertainty.
Celestica has been actively reshaping its portfolio for aerospace and defense markets. This is impacting revenues in the near term but is expected to drive profitability in the long run. Weaknesses in the capital equipment, aerospace and defense market are expected to be partially offset by healthy traction in the healthtech portfolio.
Overall Expectations
The Zacks Consensus Estimate for ATS revenues is pegged at $789.68 million, indicating a decline from $805.8 million a year ago. Net income is projected at $42.41 million.
The Zacks Consensus Estimate for total revenue is pegged at $3.45 billion, indicating 35.46% year over year growth. The consensus mark for earnings is currently pegged at $1.73 per share, indicating growth from $1.11 in the year-earlier quarter.
Earnings Whispers
Our proven model does not conclusively predict an earnings beat for Celestica for the fourth quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an earnings beat. That is not the case here.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Corning Incorporated (GLW - Free Report) is set to release quarterly numbers on Jan. 28. It has an Earnings ESP of +1.72% and carries a Zacks Rank #2.
The Earnings ESP for Amphenol Corporation (APH - Free Report) is +3.78%, and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan. 28.
The Earnings ESP for SAP (SAP - Free Report) is +0.57%, and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan. 29.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Declining ATS Revenues Hinder Celestica's Q4 Earnings?
Key Takeaways
Celestica, Inc. (CLS - Free Report) is scheduled to report fourth-quarter 2025 earnings on Jan. 28. In the to-be-reported quarter, the company is likely to have recorded lower revenues from the Advanced Technology Solutions segment owing to soft demand in some end markets and macroeconomic headwinds.
Factors at Play
The Advanced Technology Solutions (ATS) segment primarily focuses on aerospace and defense (A&D), Industrial, HealthTech and Capital Equipment businesses, which include semiconductor and display verticals.
The company is experiencing weakness in the ATS segment. Elevated inventory levels in the Industrial end markets are primarily hindering net sales growth in this segment. Although demand has stabilized, macroeconomic challenges remain headwinds. Demand in the semiconductor capital equipment market remains soft. Foundries also constrained spending on capacity buildup due to a clouded outlook in the future demand stemming from tariff and trade-related uncertainty.
Celestica has been actively reshaping its portfolio for aerospace and defense markets. This is impacting revenues in the near term but is expected to drive profitability in the long run. Weaknesses in the capital equipment, aerospace and defense market are expected to be partially offset by healthy traction in the healthtech portfolio.
Overall Expectations
The Zacks Consensus Estimate for ATS revenues is pegged at $789.68 million, indicating a decline from $805.8 million a year ago. Net income is projected at $42.41 million.
The Zacks Consensus Estimate for total revenue is pegged at $3.45 billion, indicating 35.46% year over year growth. The consensus mark for earnings is currently pegged at $1.73 per share, indicating growth from $1.11 in the year-earlier quarter.
Earnings Whispers
Our proven model does not conclusively predict an earnings beat for Celestica for the fourth quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an earnings beat. That is not the case here.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Celestica currently has an ESP of 0.00% with a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Corning Incorporated (GLW - Free Report) is set to release quarterly numbers on Jan. 28. It has an Earnings ESP of +1.72% and carries a Zacks Rank #2.
The Earnings ESP for Amphenol Corporation (APH - Free Report) is +3.78%, and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan. 28.
The Earnings ESP for SAP (SAP - Free Report) is +0.57%, and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan. 29.